Cetrorelix clinical trials: 26 trials
Page 1 of 1
Read 26 Cetrorelix clinical trials with posted results or linked papers with results in PepBank.
- Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
NCT00449150 · Phase 3 · Terminated
Posted results
- Cetrotide Treatment Optimization
NCT00866034 · Phase 4 · Terminated
Posted results
- Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH)
NCT00670306 · Phase 3 · Completed
Posted results
- Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND)
NCT03809429 · Phase 3 · Completed
Posted results
- Cetrorelix Pamoate in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)
NCT00663858 · Phase 3 · Completed
Posted results
- Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)
NCT01185704 · Phase 3 · Completed
Posted results
- Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF)
NCT01225835 · Phase 4 · Completed
Posted results
- Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders
NCT04537078 · Phase 3 · Completed
Posted results
- Outcome of Cetrotide Therapy for Management of Women at High-risk of Ovarian Hyperstimulation Syndrome
NCT02823080 · Phase 2/3 · Status unknown
Posted results
- Live Birth Rate Between PPOS and GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response
NCT04414761 · Phase 3 · Completed
Linked paper with results
- Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Patients Undergoing PGT-A
NCT04414748 · Phase 3 · Completed
Linked paper with results
- Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Women With PCOS Undergoing PGT-A
NCT05326087 · Phase 3 · Not yet recruiting
Linked paper with results
- A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation
NCT00298025 · Phase 4 · Completed
Linked paper with results
- Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles
NCT04008966 · Phase 4 · Completed
Linked paper with results
- Fixed Versus Flexible Gonadotropin-releasing Hormone (GnRH) Antagonist Initiation
NCT01005784 · Phase 4 · Completed
Linked paper with results
- Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS)
NCT01709942 · Phase 3 · Completed
Linked paper with results
- A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age
NCT01079949 · Phase 2 · Terminated
Posted results
- Lutropin Alfa in Women at Risk of Poor Response
NCT01112358 · Phase 2 · Completed
Posted results
- Gonadotropin-Releasing Hormone (GnRH)-Antagonist Therapy in Rheumatoid Arthritis
NCT00667758 · Phase 2 · Completed
Linked paper with results
- Dysregulation of FSH in Obesity: Functional and Statistical Analysis
NCT02478775 · Not applicable · Completed
Posted results
- Reproductive Hormonal Alterations in Obesity
NCT01457703 · Not applicable · Completed
Posted results
- The Role of Cetrotide Acetate in Prevention of Ovarian Hyperstimulation Syndrome (OHSS) in Oocyte Donors
NCT00867659 · Not applicable · Completed
Posted results
- PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study)
NCT06378268 · Not applicable · Active, not recruiting
Linked paper with results
- Comparison of 3 Different Protocols for Preventing Premature Ovulation in Ovarian Stimulation Cycles
NCT05767086 · Not applicable · Completed
Linked paper with results
- Ovarian Stimulation Using Recombinant Follicle-stimulating Hormone (FSH) and Gonadotrophin Releasing Hormone (GnRH) Agonist in Alternate Days
NCT01468441 · Not applicable · Completed
Linked paper with results
- Effect of GnRH Antagonist vs Agonist Long on IVF Outcome, Peak Estradiol Level,and Duration of Stimulation
NCT01669291 · Not applicable · Completed
Linked paper with results